Hormonal Drivers of Sleep Disruption
For women, the perimenopausal and menopausal transitions represent the most significant hormonal influence on sleep quality. Declining estrogen and progesterone affect sleep through multiple overlapping pathways — thermoregulatory, neurotransmitter, and neurosteroid — each of which can independently fragment sleep architecture.
Estrogen influences thermoregulation — the body's ability to maintain stable core temperature. As estrogen declines, thermoregulatory instability increases, producing hot flashes and night sweats that directly disrupt sleep continuity. Vasomotor events during sleep are accompanied by a sympathetic nervous system surge — a rapid release of norepinephrine that raises heart rate and skin conductance. This autonomic activation generates cortical micro-arousals: brief, often unremembered shifts toward lighter sleep stages that fragment sleep architecture even when the woman does not fully awaken. Estrogen also modulates serotonergic signaling, and since serotonin is the biochemical precursor to melatonin, reduced estrogen activity may indirectly attenuate the melatonin pathway already weakened by circadian aging.
Progesterone has sedative properties, but much of this effect is mediated by its neurosteroid metabolite allopregnanolone, a positive allosteric modulator of the GABA-A receptor — the same receptor system targeted by many sedative medications. Allopregnanolone enhances the activity of gamma-aminobutyric acid (GABA), the brain's primary inhibitory neurotransmitter, promoting sleep onset and maintenance. As progesterone declines during perimenopause, allopregnanolone levels fall in parallel, weakening this endogenous sedative tone and contributing to increased sleep latency and reduced sleep depth.
Cortisol — the primary stress hormone — also plays a role through the broader hypothalamic-pituitary-adrenal (HPA) axis. Under normal circadian regulation, cortisol follows a predictable diurnal pattern: a sharp cortisol awakening response shortly after waking, a gradual decline throughout the day, and a nadir during early sleep. Chronic stress, anxiety, and the physiological stress of hormonal transitions can flatten this curve, resulting in elevated evening cortisol that interferes with sleep onset and maintenance. Elevated nocturnal cortisol also stimulates hepatic gluconeogenesis, producing a counter-regulatory glucose surge that can precipitate early-morning awakening as glucose-sensitive arousal pathways activate. For broader context on hormonal transitions, see our guide on Hormonal Balance and Natural Support.